Canid secures $10M in a Series A funding to transform vaccine management with its AI-driven platform. The funding will eliminate the administrative burden for pediatricians.

Jun 03, 2025•7 months ago

Amount Raised

$10 Million

Round Type

SERIES A

New YorkMedicalArtificial IntelligenceBiotechnologyHealth CareInformation Technology

Description

Canid has successfully raised $10 million in a Series A funding to enhance its AI-driven vaccine management platform. This funding aims to streamline processes for pediatricians, reducing their administrative workload significantly. The investment will also help in further developing and deploying the technology. Canid’s innovative approach is set to revolutionize vaccine management.

Canid secures $10M in a Series A funding to transform vaccine management with its AI-driven platform. The funding will eliminate the administrative burden for pediatricians.

Description

Company Information

Related People

Funding Insights

Canid secures $10M in a Series A funding to transform vaccine management with its AI-driven platform. The funding will eliminate the administrative burden for pediatricians.

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information